SUMMARY Myoglobin levels were assayed in each urine specimen voided during 12 hours before and 48 hours after routine cardiac catheterisation in 146 patients using an indirect haemagglutination method detecting concentrations in excess of 0.015 mg/mil. Myoglobinuria was found in only one patient before but in 39 patients after cardiac catheterisation (27%), either in the first (34 patients) or the second (5 patients) post-catheterisation urine sample. Once detected, myoglobin was present in all subsequent urine specimens for the next 3 to 22 hours (mean 11 8 hours). The mean amount excreted ± SE was 14-0 ± 1-6 mg (range 2-6 to 30 mg) excluding the one patient with myoglobinuria before catheterisation. This patient, who had severe aortic stenosis and atherosclerotic heart disease, excreted 130 mg myoglobin. Patients with myoglobinuria required longer screening time to complete the procedures undertaken than those in whom myoglobin was not detected-15-6 ± 1-4 and 11-1 ± 0X6 minutes, respectively (means ± SE: P < 0.01).
When muscle is damaged it releases myoglobin into the bloodstream and this is then rapidly excreted in the urine (Kagen, 1973) . We have recently developed a simple and sensitive assay for urinary myoglobin (Cloonan et al., 1976) and have used it to quantify myoglobinuria after acute myocardial infarction . In the course of evaluating the significance of myoglobinuria, we sought evidence for this after a number of cardiovascular investigations. We report here the unexpected finding of substantial amounts of myoglobin in the urine in 27 per cent of patients undergoing cardiac catheterisation.
Subjects and methods
Investigations were done on 146 patients coming to routine cardiac catheterisation to test for myoglobinuria during the 12 hours before and the 48 hours after the procedure. The diagnoses are shown in Table 1 . The volume of each urine specimen voided was recorded and aliquots of each specimen were immediately frozen at -20°C and later tested Received for publication 7 February 1978 for the presence of myoglobin using an indirect haemagglutination method. With this method, the presence of myoglobin in the urine is detected by inhibition of agglutination of sensitised red blood cells; myoglobin reacts with the specific antibody before the addition of the cells. The method detects a minimum myoglobin concentration of 002 mg/ml and has been described fully elsewhere (Cloonan et al., 1976) .
Approximately 1 hour before cardiac catheterisation each patient received an intramuscular injection of either diazepam (0.14 mg/kg) or papaveretum (0.14 mg/kg) and hyoscine hydrobromide (003 mg/kg). Most patients with valvular heart disease (22 of 30- Table 1 ) received in addition an intramuscular injection of crystalline penicillin (2 million units) 1 hour before and 6 hours after cardiac catheterisation. The catheter study was performed by one of three experienced cardiologists using either a right brachial vessel cut-down or a percutaneous right femoral puncture approach. The procedures undertaken are shown in There was a constant pattern of excretion in those patients with myoglobinuria. Fig. 1 In 34 of the 39 myoglobin-positive patients, myoglobin was detected in the first urine specimen after cardiac catheterisation; in the remaining 5 it was present for the first time in either the second or third post-catheter specimen. Once detected, myoglobin was present in all subsequent urine specimens for the next 3 to 22 hours (mean 11 -8 hours). Excluding the one patient in whom myoglobinuria was detected before catheterisation, the mean amount of myoglobin excreted ± SE was 14-0 ± 1-6 mg, with a range of 2-6 to 30 0 mg. Fig. 2 shows the data obtained during two studies in one patient. The first study in this patient was incomplete. Right heart catheterisation was performed through a cut-down on the right brachial The screening time in the myoglobin-positive patients was 15-6 + 1-4 minutes (mean + SE) -whereas it was significantly less in those in whom it was not detected (11.1 ± 0-6 minutes; P < 0.01).
From Table 1 it can be seen that the finding of -myoglobinuria was not closely related to either diagnosis, the type of premedication, or the pro-*cedure undertaken. However, the incidence was highest in those patients with coronary artery disease whose studies routinely included a brachial artery cut-down, a combination of left and right heart catheterisation, coronary angiography, and left ventricular cine angiography. But there was no relation between the severity of coronary artery disease and the incidence of myoglobinuria among these 92 patients (X2 analysis). Eleven had less than 70 per cent obstructions of major coronary vessels and of these 3 had myoglobinuria; the other 81 patients had greater than 70 per cent obstructions and of the 24 with single vessel disease 9 had myoglobinuria, whereas 8 of the 26 with two vessel disease and 8 of the 31 with three vessel disease had myoglobinuria. Nor was there any significant relation between the amount of myoglobin excreted in the urine and the extent of coronary artery disease assessed by the number of vessels affected or myocardial function as judged by the ejection fraction measured from ventriculograms (X2 analysis).
In no patient was there any change in the electrocardiogram during the 48 hours after catheterisation to suggest evidence of cardiac muscle damage. The incidence of myoglobinuria was not influenced by the cardiologist performing the catheterisation (X2 analysis). It occurred in 10 of 45 patients (22%) studied by the first, 17 of 62 patients studied by the second (27%), and 10 of 30 patients studied by the third (33%); the remaining 7 patients were studied by experienced fellows in cardiology and myoglobinuria occurred in 2 (28%). In 6 of the 146 patients, diminished or transiently absent pulses occurred distal to the brachial artery cut-down. But of these, there was only one among the myoglobinpositive patients (see below); in the other 5 patients, myoglobinuria was not detected ( Table 2 ). The other post-catheter complications did not occur more frequently in the myoglobin-positive patients (Table 2) .
Among the 8 myoglobin-positive patients in whom pre-and post-catheterisation enzyme estimations were available, values for hydroxybutyrate dehydrogenase were the same-139 ± 22 and 135 + 27 IU/litre (means ± SE), respectively-while there was a small but statistically insignificant (paired t test) increase in creatine kinase after catheterisation from 32 ± 8 to 51 ± 16 IU/litre (means ± SE) and with the small numbers there was no significant relation in individual patients between the change in creatine kinase and the amount of myoglobin excreted. The enzyme values before and after catheterisation in the myoglobinnegative patients were virtually identical for both enzymes measured.
The patient with pre-catheter myoglobinuria was a 68-year-old woman with severe aortic stenosis but without recent or past history of chest pain suggesting myocardial ischaemia. The pre-catheter urine sample was passed at 6.30 a.m. and contained 12-5 mg myoglobin. She had had no intramuscular injections before this. The 
Discussion
So far as we are aware, this is the first report of myoglobinuria following cardiac catheterisation. Since myoglobin was detected in approximately 1 in every 4 patients submitted to this procedure, and the amounts excreted were substantial (mean 14-0 mg; range 2-6 to 30 0 mg), the mechanisms involved become particularly important.
As the method of measuring myoglobin in the urine does not distinguish between that of cardiac or skeletal muscle origin, myoglobin could have been released from either or from both types of muscle. It seems unlikely that intramuscular injections given as premedication contributed to the myoglobin release. This possibility was explored fully during an earlier study in which 15 patients were given intramuscular injections similar to those in the present study. The same method for estimating myoglobin was used and in no patient was myoglobinuria detected (Cloonan et al., 1976) . Moreover, in the present study, the incidence of myoglobinuria in the patients with valvular heart disease tended to be relatively low (see Table 1 ) despite these patients receiving intramuscular injections of 2 million units of penicillin 1 hour before and 6 hours after the procedure in addition to routine premedication. We concluded, therefore, that muscle damage resulting from intramuscular injections was not responsible for the myoglobinuria. Skeletal muscle ischaemia secondary to vessel occlusion by T. G. Donald, M. were recorded in the myoglobin-positive group whereas there were 2 of the former and 1 of the latter among the negative patients (Table 2) . It is quite likely, therefore, that the myoglobin was partly or wholly of cardiac origin. Heart muscle has a much higher myoglobin content than does skeletal muscle (Kagen, 1973 (Stone et al., 1977) who reported no significant increase in serum myoglobin levels in 9 patients after cardiac catheterisation. But, in view of the incidence of myoglobinuria we found (27%), changes may have been seen if more patients had been studied. A number of authors have described an increase in serum enzyme activity-principally of creatine kinase-in a proportion of patients after cardiac catheterisation (Marpole et al., 1968; Michie et al., 1970; Chahine et al., 1974) . In the present study there was a small increase in creatine kinase in the 8 myoglobin-positive patients for whom measurements were available-from 32 + 8 to 51 + 16 IU/litre (means ± SE). However, with these small numbers the difference was not statistically significant; nor was there a relation in individual patients between the change in creatine kinase and the amount of myoglobin excreted. Nevertheless, it may be relevant that no increase in creatine kinase occurred in the larger number (35) of myoglobinnegative patients for whom there were enzyme measurements.
There is dispute on the origin of increased postcatheter creatine kinase. Roberts and his associates (Roberts et al., 1975 ) measured serum activity before and after cardiac catheterisation of total creatine kinase as well as its MB isoenzyme which is found primarily in heart muscle. While peak total serum creatine kinase increased after catheterisation, the MB isoenzyme activity remained within normal limits. They concluded that the increase was not of cardiac origin.
However, in a recent study, Hori and his associates (Hori et al., 1976) described differences in total serum creatine kinase increases after catheterisation between patients who did and did not have selective coronary angiography and reported further that the patients with more extensive coronary vascular disease produced larger increases in serum creatine kinase after catheterisation. Our data are not in accordance with the latter observation in that in our study the extent of coronary vascular disease and variations in ejection fraction did not correlate with the amount of myoglobin excreted. Hori and his associates (Hori et a!., 1976) suggested that the raised levels represented some form of myocardial damage which is much less than that seen during acute myocardial infarction. In this context, the total amount of myoglobin excreted in the present study-14-0 ± 1'6 mg-was considerably less than -the 50 7 + 9.4 mg (P < 0-001) we obtained recently in 14 patients with uncomplicated acute myocardial infarction; and this latter amount was undoubtedly an underestimation since in 2 of the 14 patients the end-point of the excretion phase was not determined . There is, therefore, probably about a fourfold difference in excretion in the two situations. Roberts and his associates (Roberts et al., 1975) found a similar difference in serum creatine kinase enzyme activity after catheterisation and myocardial infarction. Since MB isoenzyme activity is only about 10 per cent of total activity the expected increase in the MB isoenzyme after catheterisation would be small if the creatine kinase increase were partly or wholly of cardiac origin. This might not be detected by comparing group mean values which could still remain within the normal range.
In the extreme case in the present series of the .patient with pre-catheter myoglobinuria, we con--cluded that the large amount she excreted-130 mg-was almost certainly largely of cardiac *origin. In an earlier study (Cloonan et al., 1976) we examined random urine samples in 146 control patients. Only 4 were positive for myoglobinuria and each had an adequate medical or surgical reason for skeletal muscle damage to explain this. Our present patient had critical aortic stenosis with paroxysmal nocturnal dyspnoea, a haemodynamic situation likely to produce subendocardial ischaemia (Buckberg et al., 1972) . She had, furthermore, 70 per cent and 90 per cent obstructions in two of her three main coronary arteries. We suggest that, before catheterisation, she had undetected subendocardial ischaemia with release of myoglobin which became accentuated as a result of cardiac catheterisation and selective coronary angiography. Though she did have a reduced radial pulse after the procedure, this was also noted in 5 other patients in the series and all were myoglobin-negative. The amount of myoglobinuria in this patient was of a similar order to that we have found in some patients with acute myocardial infarction .
In conclusion, we found substantial myoglobinuria in approximately 1 in 4 patients coming to routine cardiac catheterisation. It is considered likely that at least some of this myoglobin was of myocardial origin, and was related to transient and presumably completely reversible cardiac injury occurring during catheterisation and selective angiography. It seems prudent to maintain a continuing vigilance in assessing the indications for cardiac catheterisation, particularly in those patients with ischaemic heart disease in whom coronary angiography is contemplated. 
